Integrative Biomedical Research

Abedi, N., Sadeghian, A., Kouhi, M., Haugen, H.J., Savabi, O., & Nejatidanesh, F. (2025). Immunomodulation in Bone Tissue Engineering: Recent Advancements in Scaffold Design and Biological Modifications for Enhanced Regeneration. ACS Biomater Sci Eng, Mar 10;11(3):1269--90. https://doi.org/10.1021/acsbiomaterials.4c01613

Aday, S., et al. (2021). Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo. Mol Ther, Jul;29(7):2239--52. https://doi.org/10.1016/j.ymthe.2021.03.015

Akintoye, E., et al. (2018). Fish Oil and Perioperative Bleeding: Insights From the OPERA Randomized Trial. Circ Cardiovasc Qual Outcomes, Nov;11(11):e004584. https://doi.org/10.1161/CIRCOUTCOMES.118.004584

Akorede Lawal, H., et al. (2025). Overcoming barriers to the implementation of interleukin-12-based strategies in cancer immunotherapy: translational challenges, clinical integration, and public health implications. Explor Med, Aug 25;6:1001352. https://doi.org/10.37349/emed.2025.1001352

Annex, B.H. (2013). Therapeutic angiogenesis for critical limb ischaemia. Nat Rev Cardiol, Jul;10(7):387--96. https://doi.org/10.1038/nrcardio.2013.70

Annex, B.H., & Cooke, J.P. (2021). New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease. Circ Res, Jun 11;128(12):1944--57. https://doi.org/10.1161/CIRCRESAHA.121.318266

Arbade, G., Jose, J.V., Gulbake, A., Kadam, S., & Kashte, S.B. (2024). From stem cells to extracellular vesicles: a new horizon in tissue engineering and regenerative medicine. Cytotechnology, Aug;76(4):363--401. https://doi.org/10.1007/s10616-024-00631-4

Armstrong, D.G., et al. (2026). Anatomically Directed Lower Extremity Gene Therapy for Ulcer Healing: A Double-Blind, Randomized, Placebo-Controlled Study (LEGenD-1). Circ Cardiovasc Interv, Jan;19(1). https://doi.org/10.1161/CIRCINTERVENTIONS.125.015648

[No author listed]. (2024). Artificial intelligence in advance angiogenesis and inflammation research: A breakthrough in disease prediction and therapy. Journal of Angiotherapy, 8(9), 1-6. https://doi.org/10.25163/angiotherapy.899861

Augustine, R., Prasad, P., & Khalaf, I.M.N. (2019). Therapeutic angiogenesis: From conventional approaches to recent nanotechnology-based interventions. Mater Sci Eng C, Apr;97:994--1008. https://doi.org/10.1016/j.msec.2019.01.006

Bekes, I., & Wulff, C. (2019). Controlling Vascular Permeability: How Does It Work and What Is the Impact on Normal and Pathological Angiogenesis. In: Marmé D, editor. Tumor Angiogenesis [Internet]. Cham: Springer International Publishing;, [cited 2026 Jun 2]. p. 121--32. Available from: http://link.springer.com/10.1007/978-3-319-33673-2_48. https://doi.org/10.1007/978-3-319-33673-2_48

Bergers, G., & Song, S. (2005). The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncol, Oct 1;7(4):452--64. https://doi.org/10.1215/S1152851705000232

Bian, X., Ma, K., Zhang, C., & Fu, X. (2019). Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases. Stem Cell Res Ther, Dec;10(1):158. https://doi.org/10.1186/s13287-019-1276-z

Biscetti, F., & Flex, A. (2023). The Challenges in Managing Peripheral Arterial Disease Complications. Hearts, Dec 1;4(4):94--6. https://doi.org/10.3390/hearts4040012

Bora, A., et al. (2023). Risk Stratification for Diabetic Retinopathy Screening Order Using Deep Learning: A Multicenter Prospective Study. Transl Vis Sci Technol, Dec 11;12(12):11. https://doi.org/10.1167/tvst.12.12.11

Butterfield, G.L., Reisman, S.J., Iglesias, N., & Gersbach, C.A. (2025). Gene regulation technologies for gene and cell therapy. Mol Ther, May;33(5):2104--22. https://doi.org/10.1016/j.ymthe.2025.04.004

Campagna, R., Mazzanti, L., Pompei, V., Alia, S., Vignini, A., & Emanuelli, M. (2024). The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update. Cells, Sep 1;13(17):1469. https://doi.org/10.3390/cells13171469

Caradonna, E., et al. (2025). Autologous Cell Therapy for Chronic Limb Threatening Ischemia: Towards Personalized Medicine. Angiology, Oct 17;00033197251376093. https://doi.org/10.1177/00033197251376093

Carmeliet, P., et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, Apr;380(6573):435--9. https://doi.org/10.1038/380435a0

Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature, Dec;438(7070):932--6. https://doi.org/10.1038/nature04478

Castellana, E., & Chiappetta, M.R. (2025). Targeting retinal angiogenesis: sex differences in adverse reactions to anti-VEGF therapies. Ther Adv Ophthalmol, Nov;17:25158414251359587. https://doi.org/10.1177/25158414251359587

Chen, X., et al. (2023). Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease. J Biol Eng, Feb 16;17(1):13. https://doi.org/10.1186/s13036-023-00330-2

Chen, J., et al. (2025). Young-derived M2-like macrophages ameliorate hindlimb ischemia injury by promoting neovascularization in aged mice. Surgery, Aug;184:109460. https://doi.org/10.1016/j.surg.2025.109460

Chu, H., & Wang, Y. (2012). Therapeutic Angiogenesis: Controlled Delivery of Angiogenic Factors. Ther Deliv, Jun;3(6):693--714. https://doi.org/10.4155/tde.12.50

Claridge, B., Lozano, J., Poh, Q.H., & Greening, D.W. (2021). Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. Front Cell Dev Biol, Sep 20;9:734720. https://doi.org/10.3389/fcell.2021.734720

Conte, M.S., et al. (2019). Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg, Jun;69(6):3S-125S.e40. https://doi.org/10.1016/j.jvs.2019.02.016

Cressman, A., et al. (2025). Investigational New Drug-enabling studies to use genetically modified mesenchymal stromal cells in patients with critical limb ischemia. Stem Cells Transl Med, Feb 11;14(2):szae094. https://doi.org/10.1093/stcltm/szae094

Daghrery, A., De Souza Araújo, I.J., Castilho, M., Malda, J., & Bottino, M.C. (2023). Unveiling the potential of melt electrowriting in regenerative dental medicine. Acta Biomater, Jan;156:88--109. https://doi.org/10.1016/j.actbio.2022.01.010

Dave, K.M., Pinky, P.P., & S Manickam, D. (2025). Molecular engineering of extracellular vesicles for drug delivery: Strategies, challenges, and perspectives. J Controlled Release, Oct;386:114068. https://doi.org/10.1016/j.jconrel.2025.114068

De Haro, J., Acin, F., Lopez-Quintana, A., Florez, A., Martinez-Aguilar, E., & Varela, C. (2009). Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease. Heart Vessels, Sep;24(5):321--8. https://doi.org/10.1007/s00380-008-1140-z

Deev, R., et al. (2018). Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication. Ther Adv Cardiovasc Dis, Sep;12(9):237--46. https://doi.org/10.1177/1753944718786926

Deshmukh, T., & Chong, J.J.H. (2023). Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and Beyond. Heart Lung Circ, Jul;32(7):798--807. https://doi.org/10.1016/j.hlc.2023.05.018

Di, X., et al. (2025). Seltoplasmid promotes ulcer healing versus placebo for treating patients with chronic limb-threatening ischemia: HOPE CLTI-2 trial. Mol Ther, Jul;33(7):3423--33. https://doi.org/10.1016/j.ymthe.2025.04.009

Dong, J., et al. (2004). VEGF-null cells require PDGFR α signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J, Jul 21;23(14):2800--10. https://doi.org/10.1038/sj.emboj.7600289

Dong, S., et al. (2025). Therapeutic Hydrogels: Properties and Biomedical Applications. Chem Rev, Sep 24;125(18):8835--920. https://doi.org/10.1021/acs.chemrev.5c00182

Du Cheyne, C., Tay, H., & De Spiegelaere, W. (2020). The complex TIE between macrophages and angiogenesis. Anat Histol Embryol, Sep;49(5):585--96. https://doi.org/10.1111/ahe.12518

Dudley, A.C., & Griffioen, A.W. (2023). Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis, Aug;26(3):313--47. https://doi.org/10.1007/s10456-023-09876-7

Dumitru, C.S., & Raica, M. (2024). A Splice Form of VEGF, a Potential Anti-Angiogenetic Form of Head and Neck Squamous Cell Cancer Inhibition. Int J Mol Sci, Aug 14;25(16):8855. https://doi.org/10.3390/ijms25168855

Engler, D.A. (1996). Use of Vascular Endothelial Growth Factor for Therapeutic Angiogenesis. Circulation, Oct;94(7):1496--8. https://doi.org/10.1161/01.CIR.94.7.1496

Fan, W., et al. (2024). A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis. Genome Biol, Jun 25;25(1):165. https://doi.org/10.1186/s13059-024-03308-5

Fang, S., & Salven, P. (2015). Role of Stem Cells in Angiogenesis. In: Hayat MA, editor. Stem Cells and Cancer Stem Cells, Volume 13 [Internet]. Dordrecht: Springer Netherlands;, [cited 2026 Jun 2]. p. 101--8. (Stem Cells and Cancer Stem Cells). Available from: https://link.springer.com/10.1007/978-94-017-7233-4_8. https://doi.org/10.1007/978-94-017-7233-4_8

Ferrara, N. (2004). Vascular Endothelial Growth Factor: Basic Science and Clinical Progress. Endocr Rev, Aug 1;25(4):581--611. https://doi.org/10.1210/er.2003-0027

Ferrara, N., & Kerbel, R.S. (2005). Angiogenesis as a therapeutic target. Nature, Dec;438(7070):967--74. https://doi.org/10.1038/nature04483

Filion, R.J., & Popel, A.S. (2005). Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention. Am J Physiol-Heart Circ Physiol, Jan;288(1):H263--79. https://doi.org/10.1152/ajpheart.00205.2004

Frolov, A., et al. (2023). Multi-Omics Profiling of Human Endothelial Cells from the Coronary Artery and Internal Thoracic Artery Reveals Molecular but Not Functional Heterogeneity. Int J Mol Sci, Oct 9;24(19):15032. https://doi.org/10.3390/ijms241915032

Gagliardi, A., et al. (2021). Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors. Front Pharmacol, Feb 3;12:601626. https://doi.org/10.3389/fphar.2021.601626

Galaviz, K.I., & Barnes, G.D. (2021). Implementation Science Opportunities in Cardiovascular Medicine. Circ Cardiovasc Qual Outcomes, Jul;14(7). https://doi.org/10.1161/CIRCOUTCOMES.121.008109

Garmany, A., & Terzic, A. (2024). Artificial intelligence powers regenerative medicine into predictive realm. Regen Med, Dec;19(12):611--6. https://doi.org/10.1080/17460751.2024.2437281

Gerhardt, H., & Betsholtz, C. (2003). Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res, Oct 1;314(1):15--23. https://doi.org/10.1007/s00441-003-0745-x

Giacca, M., & Zacchigna, S. (2012). VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther, Jun;19(6):622--9. https://doi.org/10.1038/gt.2012.17

Gianni-Barrera, R., et al. (2020). Therapeutic vascularization in regenerative medicine. Stem Cells Transl Med, Apr 1;9(4):433--44. https://doi.org/10.1002/sctm.19-0319

Gornik, H.L., et al. (2024). ., ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jun 11;149(24). https://doi.org/10.1161/CIR.0000000000001251

Graney, P.L., et al. (2020). Macrophages of diverse phenotypes drive vascularization of engineered tissues. Sci Adv, May;6(18):eaay6391. https://doi.org/10.1126/sciadv.aay6391

Grigorean, V.T., et al. (2026). Mapping the Ischemic Continuum: Dynamic Multi-Omic Biomarker and AI for Personalized Stroke Care. Int J Mol Sci, Jan 3;27(1):502. https://doi.org/10.3390/ijms27010502

Grundmann, S., Piek, J.J., Pasterkamp, G., & Hoefer, I.E. (2007). Arteriogenesis: basic mechanisms and therapeutic stimulation. Eur J Clin Invest, Oct;37(10):755--66. https://doi.org/10.1111/j.1365-2362.2007.01861.x

Guddeti, R.R., et al. (2025). A VEGF gene therapy approach for the treatment of patients with coronary artery disease and refractory angina: assessment of clinical development. Expert Opin Investig Drugs, May 4;34(5):363--70. https://doi.org/10.1080/13543784.2025.2510666

Guo, H., et al. (2025). The impact of natural and engineered extracellular vesicles on post-myocardial infarction angiogenesis. Stem Cell Res Ther, Nov 25;16(1):658. https://doi.org/10.1186/s13287-025-04785-6

Han, Z., et al. (2022). Efficient angiogenesis-based wound healing through hydrogel dressing with extracellular vesicles release. Mater Today Bio, Dec;16:100427. https://doi.org/10.1016/j.mtbio.2022.100427

Han, L., et al. (2024). Dapagliflozin Improves Angiogenesis after Hindlimb Ischemia through the PI3K-Akt-eNOS Pathway. Biomolecules, May 16;14(5):592. https://doi.org/10.3390/biom14050592

Hanna, E., Rémuzat, C., Auquier, P., & Toumi, M. (2016). Advanced therapy medicinal products: current and future perspectives. J Mark Access Health Policy, Jan;4(1):31036. https://doi.org/10.3402/jmahp.v4.31036

Hassanpour, M., Salybekov, A.A., Kobayashi, S., & Asahara, T. (2023). CD34 positive cells as endothelial progenitor cells in biology and medicine. Front Cell Dev Biol, Apr 17;11:1128134. https://doi.org/10.3389/fcell.2023.1128134

Hassanzadeh, A., et al. (2021). Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther, May 21;12(1):297. https://doi.org/10.1186/s13287-021-02378-7

Hedayati, N., et al. (2025). Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity. Discov Oncol, May 5;16(1):669. https://doi.org/10.1007/s12672-025-02471-w

Hellberg, C., Östman, A., & Heldin, C.H. (2010). PDGF and Vessel Maturation. In: Liersch R, Berdel WE, Kessler T, editors. Angiogenesis Inhibition [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg;, [cited 2026 Jun 2]. p. 103--14. (Recent Results in Cancer Research). Available from: http://link.springer.com/10.1007/978-3-540-78281-0_7. https://doi.org/10.1007/978-3-540-78281-0_7

Henry, T.D., et al. (2003). The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis. Circulation, Mar 18;107(10):1359--65. https://doi.org/10.1161/01.CIR.0000061911.47710.8A

Huang, K., et al. (2025). Angiogenesis during diabetic wound repair: from mechanism to therapy opportunity. Burns Trauma, Jan 2;13:tkae052. https://doi.org/10.1093/burnst/tkae052

Izadpanah, R., Izadpanah, A., & Alt, E.U. (2025). Dual faces of angiogenesis: Mechanisms and therapeutic applications. Biochim Biophys Acta BBA - Rev Cancer, Nov;1880(6):189494. https://doi.org/10.1016/j.bbcan.2025.189494

Jarrige, M., et al. (2021). The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles. Cells, Jan 27;10(2):240. https://doi.org/10.3390/cells10020240

Jiang, J., et al. (2025). Biomaterial-based strategies for bone cement: modulating the bone microenvironment and promoting regeneration. J Nanobiotechnology, May 13;23(1):343. https://doi.org/10.1186/s12951-025-03363-5

Jude, E., & Wang, H. (2026). Diabetes, Obesity, and the Metabolic Drivers of Peripheral Artery Disease: Lessons from Recent Forecasts. Vasc Health Risk Manag, Feb;Volume 22:1--3. https://doi.org/10.2147/VHRM.S576743

Kantor, B., et al. (2024). The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders. Nat Commun, Aug 23;15(1):7259. https://doi.org/10.1038/s41467-024-50515-6

Kolluru, G.K., Bir, S.C., & Kevil, C.G. (2012). Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing. Int J Vasc Med, 2012:1--30. https://doi.org/10.1155/2012/918267

Kukharchuk, O. (2024). Fetal progenitor cells for treatment of chronic limb ischemia. Am J Stem Cells, 13(3):169--90. https://doi.org/10.62347/MZKI8393

Käßmeyer, S., Plendl, J., Custodis, P., & Bahramsoltani, M. (2009). New Insights in Vascular Development: Vasculogenesis and Endothelial Progenitor Cells. Anat Histol Embryol, Feb;38(1):1--11. https://doi.org/10.1111/j.1439-0264.2008.00894.x

Larionova, I., Kazakova, E., Gerashchenko, T., & Kzhyshkowska, J. (2021). New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis. Cancers, Jun 29;13(13):3253. https://doi.org/10.3390/cancers13133253

Le Du, J., & Ronco, C. (2025). Therapeutic strategies targeting ocular vasculopathies: Current advances and emerging challenges. Drug Discov Today, Nov;30(11):104496. https://doi.org/10.1016/j.drudis.2025.104496

Lekas, M., Lekas, P., Latter, D.A., Kutryk, M.B., & Stewart, D.J. (2006). Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Curr Opin Cardiol., Jul;21(4):376--84. https://doi.org/10.1097/01.hco.0000231409.69307.d2

Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V., & Ferrara, N. (1989). Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen. Science, Dec 8;246(4935):1306--9. https://doi.org/10.1126/science.2479986

Li, Q., et al. (2021). Engineering extracellular vesicles with platelet membranes fusion enhanced targeted therapeutic angiogenesis in a mouse model of myocardial ischemia reperfusion. Theranostics, 11(8):3916--31. https://doi.org/10.7150/thno.52496

Li, G., Gao, J., Ding, P., & Gao, Y. (2025). The role of endothelial cell--pericyte interactions in vascularization and diseases. J Adv Res, Jan;67:269--88. https://doi.org/10.1016/j.jare.2024.01.016

Liang, W., et al. (2025). Mg--Sc alloy promotes angiogenesis--osteogenesis coupling and ameliorates steroid-induced osteonecrosis of the femoral head. Rare Met, Sep;44(9):6707--29. https://doi.org/10.1007/s12598-025-03322-x

Liu, Y., Lyons, C.J., Ayu, C., & O'Brien, T. (2024). Recent advances in endothelial colony-forming cells: from the transcriptomic perspective. J Transl Med, Mar 26;22(1):313. https://doi.org/10.1186/s12967-024-05108-8

Liu, X., et al. (2025). Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies. Biomark Res, Apr 18;13(1):62. https://doi.org/10.1186/s40364-025-00779-x

Liu, H., et al. (2025). Current status, challenges, and prospects of artificial intelligence applications in wound repair theranostics. Theranostics, Jan 2;15(5):1662--88. https://doi.org/10.7150/thno.105109

Luo, Z., Yao, J., Wang, Z., & Xu, J. (2023). Mitochondria in endothelial cells angiogenesis and function: current understanding and future perspectives. J Transl Med, Jul 5;21(1):441. https://doi.org/10.1186/s12967-023-04286-1

Malecic, N., & Young, H.S. (2017). Excessive angiogenesis associated with psoriasis as a cause for cardiovascular ischaemia. Exp Dermatol, Apr;26(4):299--304. https://doi.org/10.1111/exd.13310

Malhi, N.K., Southerland, K.W., Lai, L., & Chen, Z.B. (2023). Epigenetic Regulation of Angiogenesis in Peripheral Artery Disease. Methodist DeBakey Cardiovasc J, Nov 16;19(5):47--57. https://doi.org/10.14797/mdcvj.1294

Mancuso, M.R., et al. (2006). Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest, Oct 2;116(10):2610--21. https://doi.org/10.1172/JCI24612

Marouf, A.A., Rokne, J.G., & Alhajj, R. (2025). Integrating Multi-Omics and Medical Imaging in Artificial Intelligence-Based Cancer Research: An Umbrella Review of Fusion Strategies and Applications. Cancers, Nov 13;17(22):3638. https://doi.org/10.3390/cancers17223638

Masumoto, S., Ono, A., Ito, A., Kawabe, Y., & Kamihira, M. (2021). Hypoxia-responsive expression of vascular endothelial growth factor for induction of angiogenesis in artificial three-dimensional tissues. J Biosci Bioeng, Oct;132(4):399--407. https://doi.org/10.1016/j.jbiosc.2021.06.010

Mentkowski, K.I., Tarvirdizadeh, T., Manzanero, C.A., Eagler, L.A., & Lang, J.K. (2024). Surface engineering enhances the therapeutic potential of systemically delivered extracellular vesicles following acute myocardial infarction. FASEB J, Sep 30;38(18):e70070. https://doi.org/10.1096/fj.202400828R

Moccia, F., Antognazza, M.R., & Lodola, F. (2021). Towards Novel Geneless Approaches for Therapeutic Angiogenesis. Front Physiol, Jan 20;11:616189. https://doi.org/10.3389/fphys.2020.616189

Moise, N., et al. (2022). Leveraging Implementation Science for Cardiovascular Health Equity: A Scientific Statement From the American Heart Association. Circulation, Nov 8;146(19). https://doi.org/10.1161/CIR.0000000000001096

Morphofunctional basis of the diferent types of angiogenesis and formation of postnatal angiogenesis-related secondary, s.t.r.u.c.t.u.r.e.s. (2017). Histol Histopathol., Sep;32:1239--79. https://doi.org/10.14670/HH-11-923

Morrison, A.R., et al. (2014). Chemokine-coupled β2 integrin--induced macrophage Rac2--Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis. J Exp Med, Sep 22;211(10):1957--68. https://doi.org/10.1084/jem.20132130

Muppala, S. (2021). Growth Factor-Induced Angiogenesis in Hepatocellular Carcinoma. Crit Rev Oncog, 26(1):61--8. https://doi.org/10.1615/CritRevOncog.2020035703

Murayama, T., & Asahara, T. (2002). Bone marrow-derived endothelial progenitor cells for vascular regeneration. Curr Opin Mol Ther, Aug;4(4):395--402. PubMed PMID: 12222878.

Nazarnezhad, S., Baino, F., Kim, H.W., Webster, T.J., & Kargozar, S. (2020). Electrospun Nanofibers for Improved Angiogenesis: Promises for Tissue Engineering Applications. Nanomaterials, Aug 17;10(8):1609. https://doi.org/10.3390/nano10081609

Ngo Ntjam, N., et al. (2021). Cardiovascular Adverse Events With Intravitreal Anti--Vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Ophthalmol, Jun 1;139(6):610. https://doi.org/10.1001/jamaophthalmol.2021.0640

Oronsky, B.T., Scicinski, J.J., Reid, T., & Knox, S. (2012). Beyond Antiangiogenesis: Vascular Modulation as an Anticancer Therapy---A Review. Transl Oncol, Jun;5(3):133--40. https://doi.org/10.1593/tlo.12118

Otth, M., Drozdov, D., & Scheinemann, K. (2022). Feasibility of a registry for standardized assessment of long-term and late-onset health events in survivors of childhood and adolescent cancer. Sci Rep, Aug 26;12(1):14617. https://doi.org/10.1038/s41598-022-18962-7

Ouma, G.O., Jonas, R.A., Usman, M.H.U., & Mohler, E.R. (2012). Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease. Vasc Med, Jun;17(3):174--92. https://doi.org/10.1177/1358863X12438270

Patel, J.C., Shukla, M., & Shukla, M. (2025). From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence. Front Bioeng Biotechnol, Jul 30;13:1639439. https://doi.org/10.3389/fbioe.2025.1639439

Peeters, J.A.H.M., Schepers, A., Hamming, J.F., & Quax, P.H.A. (2024). Therapeutic angiogenesis for patients with chronic limb-threatening ischemia: promising or hoax? Vasc Biol., Oct 7;6(1):e240009. https://doi.org/10.1530/VB-24-0009

Peirce, S.M., Price, R.J., & Skalak, T.C. (2004). Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF~164~ and Ang-1*. Am J Physiol-Heart Circ Physiol, Mar;286(3):H918--25. https://doi.org/10.1152/ajpheart.00833.2003

Pollak, R., et al. (2025). Human Placenta-Derived Cells ( [PDA]{.smallcaps} -002) in Diabetic Foot Ulcer Patients With and Without Peripheral Artery Disease: A Phase 2 Multi-Center, Randomised, Double-Blind, Placebo-Controlled Trial. Int Wound J, Oct;22(10):e70769. https://doi.org/10.1111/iwj.70769

Qin, Y., et al. (2025). A metamaterial scaffold beyond modulus limits: enhanced osteogenesis and angiogenesis of critical bone defects. Nat Commun, Mar 4;16(1):2180. https://doi.org/10.1038/s41467-025-57609-9

Rafati, F., et al. (2026). Smart integrated biomaterial systems for precision and optimized delivery of MSCs and their exosomes: Transforming wound healing and organ regeneration. Regen Ther, Mar;31:101045. https://doi.org/10.1016/j.reth.2025.101045

Rehak, L., et al. (2024). The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)---Rationale and Meta-Analysis of Observational Studies. J Clin Med, Nov 28;13(23):7230. https://doi.org/10.3390/jcm13237230

Ribatti, D., & Crivellato, E. (2012). "Sprouting angiogenesis", a reappraisal. Dev Biol, Dec;372(2):157--65. https://doi.org/10.1016/j.ydbio.2012.09.018

Ribatti, D., Solimando, A.G., & Pezzella, F. (2021). The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer. Cancers, Jul 8;13(14):3433. https://doi.org/10.3390/cancers13143433

Ribieras, A.J., Ortiz, Y.Y., Liu, Z.J., & Velazquez, O.C. (2022). Therapeutic angiogenesis in Buerger's disease: reviewing the treatment landscape. Ther Adv Rare Dis, Jan;3:26330040211070295. https://doi.org/10.1177/26330040211070295

Rosengart, T.K., et al. (1999). Angiogenesis Gene Therapy: Phase I Assessment of Direct Intramyocardial Administration of an Adenovirus Vector Expressing VEGF121 cDNA to Individuals With Clinically Significant Severe Coronary Artery Disease. Circulation, Aug 3;100(5):468--74. https://doi.org/10.1161/01.CIR.100.5.468

Rosengart, T.K., et al. (2013). Long-Term Follow-Up Assessment of a Phase 1 Trial of Angiogenic Gene Therapy Using Direct Intramyocardial Administration of an Adenoviral Vector Expressing the VEGF121 cDNA for the Treatment of Diffuse Coronary Artery Disease. Hum Gene Ther, Feb;24(2):203--8. https://doi.org/10.1089/hum.2012.137

Sabra, M., Karbasiafshar, C., Aboulgheit, A., Raj, S., Abid, M.R., & Sellke, F.W. (2021). Clinical Application of Novel Therapies for Coronary Angiogenesis: Overview, Challenges, and Prospects. Int J Mol Sci, Apr 2;22(7):3722. https://doi.org/10.3390/ijms22073722

Schwartz, M.A. (2010). Integrins and Extracellular Matrix in Mechanotransduction. Cold Spring Harb Perspect Biol, Dec 1;2(12):a005066--a005066. https://doi.org/10.1101/cshperspect.a005066

Selvaprithviraj, V., Sankar, D., Sivashanmugam, A., Srinivasan, S., & Jayakumar, R. (2017). Pro-angiogenic Molecules for Therapeutic Angiogenesis. Curr Med Chem, Oct 25;24(31). https://doi.org/10.2174/0929867324666170724142641

Semenza, G.L. (2007). Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling. J Cell Biochem, Nov;102(4):840--7. https://doi.org/10.1002/jcb.21523

Sharma, S., et al. (2025). Macrophage Proangiogenic VEGF-A Is Required for Inflammatory Arteriogenesis During Vascular Injury. Biomedicines, Mar 31;13(4):828. https://doi.org/10.3390/biomedicines13040828

Sherwood, L.M., Parris, E.E., & Folkman, J. (1971). Tumor Angiogenesis: Therapeutic Implications. N Engl J Med, Nov 18;285(21):1182--6. https://doi.org/10.1056/NEJM197111182852108

Shi, L., et al. (2026). Engineered extracellular vesicles for precision renal therapy: Bioengineering strategies and clinical translation. Interdiscip Med, May;4(3):e70116. https://doi.org/10.1002/inmd.70116

Shibuya, M. (2011). Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. Genes Cancer, Dec 1;2(12):1097--105. https://doi.org/10.1177/1947601911423031

Silva, E.A., & Mooney, D.J. (2010). Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials, Feb;31(6):1235--41. https://doi.org/10.1016/j.biomaterials.2009.10.052

Simons, M., et al. (2000). Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus: An Expert Panel Summary. Circulation, Sep 12;102(11). https://doi.org/10.1161/01.CIR.102.11.e73

Skouras, P., Gargalionis, A.N., & Piperi, C. (2023). Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas. Int J Mol Sci, Jun 15;24(12):10162. https://doi.org/10.3390/ijms241210162

Song, P., Xu, Y., Zha, M., Zhang, Y., & Rudan, I. (2019). Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health, Jun;9(1):010427. https://doi.org/10.7189/jogh.09.010427

Spadaccio, C., et al. (2022). The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization. J Cardiovasc Transl Res, Oct;15(5):1024--48. https://doi.org/10.1007/s12265-022-10241-0

Spiller, K.L., et al. (2014). The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials, May;35(15):4477--88. https://doi.org/10.1016/j.biomaterials.2014.02.012

Stewart, D.J., et al. (2009). VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial. Mol Ther, Jun;17(6):1109--15. https://doi.org/10.1038/mt.2009.70

Su, Y., Lu, J., Liang, F., & Cheng, J. (2025). Hypoxia-Induced Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Regulate Macrophage Polarization and Enhance Angiogenesis to Promote Diabetic Wound Healing. Biomolecules, Oct 24;15(11):1504. https://doi.org/10.3390/biom15111504

Subramanian, I., Verma, S., Kumar, S., Jere, A., & Anamika, K. (2020). Multi-omics Data Integration, Interpretation, and Its Application. Bioinforma Biol Insights, Jan;14:117793221989905. https://doi.org/10.1177/1177932219899051

Suchting, S., et al. (2007). The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A, Feb 27;104(9):3225--30. https://doi.org/10.1073/pnas.0611177104

Sui, J., et al. (2026). Engineering Extracellular Vesicles for Tumor Targeted Therapy: Source Optimization, Modification, and Clinical Application. Int J Nanomedicine, Apr;Volume 21:1--23. https://doi.org/10.2147/IJN.S592579

Tan, Q., Liu, M., & Tao, X. (2025). Targeting Lactylation: From Metabolic Reprogramming to Precision Therapeutics in Liver Diseases. Biomolecules, Aug 16;15(8):1178. https://doi.org/10.3390/biom15081178

Targeting Angiogenesis and Growth Factor Pathways: Implications for Cancer Therapy and Tumor Microenvironment, R.e.g.u.l.a.t.i.o.n. (2024). J Angiother., Nov 1;8(11):1--8. https://doi.org/10.25163/angiotherapy.8115316

Tariq, A.R., Lee, M., & Kim, M. (2024). Endothelial Progenitor Cells: A Brief Update. Int J Stem Cells, Nov 30;17(4):374--80. https://doi.org/10.15283/ijsc23106

Thiruchelvam, U., Dransfield, I., Saunders, P.T.K., & Critchley, H.O.D. (2013). The importance of the macrophage within the human endometrium. J Leukoc Biol, Feb 1;93(2):217--25. https://doi.org/10.1189/jlb.0712327

Thurston, G., & Daly, C. (2012). The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway. Cold Spring Harb Perspect Med, Sep 1;2(9):a006650--a006650. https://doi.org/10.1101/cshperspect.a006650

Tie, Y., Tang, F., Peng, D., Zhang, Y., & Shi, H. (2022). TGF-beta signal transduction: biology, function and therapy for diseases. Mol Biomed, Dec 19;3(1):45. https://doi.org/10.1186/s43556-022-00109-9

Tiwari, A., Trivedi, R., & Lin, S.Y. (2022). Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci, Oct 17;29(1):83. https://doi.org/10.1186/s12929-022-00866-3

Tong, H., et al. (2024). Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation. Cell Metab, Dec;36(12):2493-2510.e9. https://doi.org/10.1016/j.cmet.2024.10.019

Traversa, D., & Chiara, M. (2025). Mapping Cell Identity from scRNA-seq: A primer on computational methods. Comput Struct Biotechnol J, Jan;27:1559--69. https://doi.org/10.1016/j.csbj.2025.03.051

Tu, Y., et al. (2026). Growth factor applications and clinical translation: advances and challenges. Ann Med, Dec 31;58(1):2642893. https://doi.org/10.1080/07853890.2026.2642893

Uccelli, A., et al. (2019). Vascular endothelial growth factor biology for regenerative angiogenesis. Swiss Med Wkly, Jan 27;149(0304):w20011. https://doi.org/10.4414/smw.2019.20011

Van Oostrom, M.C., Van Oostrom, O., Quax, P.H.A., Verhaar, M.C., & Hoefer, I.E. (2008). Insights into mechanisms behind arteriogenesis: what does the future hold? J Leukoc Biol., Dec 1;84(6):1379--91. https://doi.org/10.1189/jlb.0508281

Vincent, K.A., Jiang, C., Boltje, I., & Kelly, R.A. (2007). Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease. Gene Ther, May;14(10):781--9. https://doi.org/10.1038/sj.gt.3302953

Wakabayashi, T., & Naito, H. (2023). Cellular heterogeneity and stem cells of vascular endothelial cells in blood vessel formation and homeostasis: Insights from single-cell RNA sequencing. Front Cell Dev Biol, Mar 21;11:1146399. https://doi.org/10.3389/fcell.2023.1146399

Wang, Y., Kankala, R.K., Ou, C., Chen, A., & Yang, Z. (2022). Advances in hydrogel-based vascularized tissues for tissue repair and drug screening. Bioact Mater, Mar;9:198--220. https://doi.org/10.1016/j.bioactmat.2021.07.005

Wang, L., et al. (2022). Key considerations on the development of biodegradable biomaterials for clinical translation of medical devices: With cartilage repair products as an example. Bioact Mater, Mar;9:332--42. https://doi.org/10.1016/j.bioactmat.2021.07.031

Wang, X., et al. (2023). YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2. Genome Biol, Apr 21;24(1):87. https://doi.org/10.1186/s13059-023-02931-y

Wang, Z. (2023). Assessing Tumorigenicity in Stem Cell-Derived Therapeutic Products: A Critical Step in Safeguarding Regenerative Medicine. Bioengineering, Jul 19;10(7):857. https://doi.org/10.3390/bioengineering10070857

Wang, J.H., Gessler, D.J., Zhan, W., Gallagher, T.L., & Gao, G. (2024). Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther, Apr 3;9(1):78. https://doi.org/10.1038/s41392-024-01780-w

Wang, M., et al. (2024). Design Strategies and Application Potential of Multifunctional Hydrogels for Promoting Angiogenesis. Int J Nanomedicine, Nov;Volume 19:12719--42. https://doi.org/10.2147/IJN.S495971

Wang, P., et al. (2025). Advancements in Gene-Based Therapeutic Angiogenesis for Chronic Limb-Threatening Ischemia. Hum Gene Ther, May;36(9--10):787--800. https://doi.org/10.1089/hum.2024.245

Wang, Z., et al. (2025). 4D printing polymeric biomaterials for adaptive tissue regeneration. Bioact Mater, Jun;48:370--99. https://doi.org/10.1016/j.bioactmat.2025.01.033

Wang, H., et al. (2025). Empagliflozin-Pretreated MSC-Derived Exosomes Enhance Angiogenesis and Wound Healing via PTEN/AKT/VEGF Pathway. Int J Nanomedicine, Apr;Volume 20:5119--36. https://doi.org/10.2147/IJN.S512074

Wang, X., et al. (2025). Lactate-binding protein DNMT3A in HRMECs promotes angiogenesis by upregulating VEGFA through HIF-1α lactylation. Genome Biol, Oct 30;26(1):377. https://doi.org/10.1186/s13059-025-03845-7

Williams, C.B., Yeh, E.S., & Soloff, A.C. (2016). Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. Npj Breast Cancer, Jan 20;2(1):15025. https://doi.org/10.1038/npjbcancer.2015.25

Wu, W., et al. (2023). Phosphoinositide 3-kinase as a therapeutic target in angiogenic disease. Exp Eye Res, Nov;236:109646. https://doi.org/10.1016/j.exer.2023.109646

Wu, P., et al. (2023). The marriage of immunomodulatory, angiogenic, and osteogenic capabilities in a piezoelectric hydrogel tissue engineering scaffold for military medicine. Mil Med Res, Jul 31;10(1):35. https://doi.org/10.1186/s40779-023-00469-5

Xia, Y., Wu, P., Chen, H., & Chen, Z. (2024). Advances in stem cell therapy for diabetic foot. Front Genet, Sep 3;15:1427205. https://doi.org/10.3389/fgene.2024.1427205

Xie, Z., et al. (2024). Endothelial cell heterogeneity in colorectal cancer: tip cells drive angiogenesis. Cell Mol Life Sci, Dec;81(1):365. https://doi.org/10.1007/s00018-024-05411-z

Xu, D., et al. (2018). Long-term Progression of Type 1 Neovascularization in Age-related Macular Degeneration Using Optical Coherence Tomography Angiography. Am J Ophthalmol, Mar;187:10--20. https://doi.org/10.1016/j.ajo.2017.12.005

Yang, Y., et al. (2024). Hydrogel Loaded with Extracellular Vesicles: An Emerging Strategy for Wound Healing. Pharmaceuticals, Jul 10;17(7):923. https://doi.org/10.3390/ph17070923

Yoo, S.Y., & Kwon, S.M. (2013). Angiogenesis and Its Therapeutic Opportunities. Mediators Inflamm, 2013:1--11. https://doi.org/10.1155/2013/127170

Youssef, E., Weddle, K., Zimmerman, L., & Palmer, D. (2026). Pharmacovigilance in Cell and Gene Therapy: Evolving Challenges in Risk Management and Long-Term Follow-Up. Drug Saf, Jan;49(1):27--53. https://doi.org/10.1007/s40264-025-01596-9

Zachary, I., & Morgan, R.D. (2011). Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart, Feb 1;97(3):181--9. https://doi.org/10.1136/hrt.2009.180414

Zang, G., et al. (2025). IDH2 lactylation promotes angiogenesis in murine diabetic myocardial infarction via blocking Cav1-eNOS interaction. Nat Commun, Dec 19;17(1):1117. https://doi.org/10.1038/s41467-025-67877-0

Zarubova, J., Hasani-Sadrabadi, M.M., Ardehali, R., & Li, S. (2022). Immunoengineering strategies to enhance vascularization and tissue regeneration. Adv Drug Deliv Rev, May;184:114233. https://doi.org/10.1016/j.addr.2022.114233

Zhang, H., Dellsperger, K.C., & Zhang, C. (2012). The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update. Basic Res Cardiol, Jan;107(1):237. https://doi.org/10.1007/s00395-011-0237-1

Zhang, Y., et al. (2014). PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells. Int J Clin Exp Pathol, 7(11):8112--7. PubMed PMID: 25550859; PubMed Central PMCID: PMC4270588.

Zhang, D., et al. (2019). Metabolic regulation of gene expression by histone lactylation. Nature, Oct 24;574(7779):575--80. https://doi.org/10.1038/s41586-019-1678-1

Zhang, S.M., Wei, C.Y., Wang, Q., Wang, L., Lu, L., & Qi, F.Z. (2021). M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1/2, and STAT3 signaling pathways. Mol Biol Rep, Sep;48(9):6443--56. https://doi.org/10.1007/s11033-021-06646-w

Zhang, Q., et al. (2022). CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction. Mol Med, Dec;28(1):145. https://doi.org/10.1186/s10020-022-00575-5

Zhang, A.B., et al. (2023). Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma. Cancers, Jan 29;15(3):830. https://doi.org/10.3390/cancers15030830

Zhang, W., et al. (2024). Advanced gene nanocarriers/scaffolds in nonviral-mediated delivery system for tissue regeneration and repair. J Nanobiotechnology, Jun 26;22(1):376. https://doi.org/10.1186/s12951-024-02580-8

Zhu, W., Xu, Z., Zhou, D., Xu, J., He, Y., & Li, Z.A. (2025). Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head. J Tissue Eng, Nov;16:20417314241310541. https://doi.org/10.1177/20417314241310541

Zhu, L., Wang, J., Liu, Z., Chen, K., Wu, Z., & Wang, Y. (2025). Acellular fishbone scaffolds loaded with bone marrow mesenchymal stem cell-derived exosomes for bone defect repairing. J Nanobiotechnology, Dec 22;23(1):793. https://doi.org/10.1186/s12951-025-03961-3

Ziello, J.E., Jovin, I.S., & Huang, Y. (2007). Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med, Jun;80(2):51--60. PubMed PMID: 18160990; PubMed Central PMCID: PMC2140184.